Intensive Studies for Recertification: Compounded Sterile Preparations Pharmacy (Cert #L249177)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in compounded sterile preparations pharmacy.

Board-certified pharmacists are eligible to receive up to 6.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

ASHP is approved by BPS as a provider for the recertification of BCSCP.

USP <800>: Focus on Compounding and Administration - Pharmacy and Nursing Safe Practices
ACPE #: 0204-0000-23-236-H07-P

• Choose the facility designs compliant with USP <800> and related USP chapters and the reason for inclusion of each element
• Identify the work practices that support safe sterile and nonsterile hazardous drug compounding
• Apply work practices that support safe administration of hazardous drugs, including oncology agents and drugs with reproductive risks 

Compounding A, B, C’s: Following Categories 1, 2, and 3
ACPE #: 0204-0000-23-260-H07-P

• Given a compounded sterile preparation (CSP) and the conditions in which it is prepared, assign the proper beyond-use date (BUD)
• Apply best practices for the preparation of immediate use CSPs
• Differentiate between operational requirements of USP Chapter <797> Categories 1, 2, and 3 

Sterile Compounding: Standards, Regulations, and Best Practices
ACPE #: 0204-0000-24-133-H07-P

• Identify standards and regulations that apply to sterile compounding.
• Assess facility and personnel scenarios for compliance with USP standards.
• Select the appropriate mitigation strategy for environmental excursions. 

Designing a Competency Assessment Program for Compounded Sterile Preparations
ACPE #: 0204-0000-24-135-H07-P

• Describe the core competencies required by USP Chapter <797>.
• Summarize the principles associated with competency design and development.
• Identify competency design strategies that will ensure ongoing compliance with USP <797> and data maintenance. 

Unlocking the Secrets of Surface Sample Collection and Media Analysis
ACPE #: 0204-0000-24-136-H07-P

• List the ideal characteristics of solid and liquid media used for USP <797> testing.
• Explain each step in the surface sample collection process.
• Evaluate the challenges associated with reading sample collection devices and media-fill tests.

Full faculty bios 

Angela Cassano PharmD, BCPS, FASHP*
President
Pharmfusion Consulting, LLC
Midlothian, Virginia 

Kevin Hansen, PharmD, MS, BCPS, BCSCP*
Assistant Director of Pharmacy (Sterile Products, Special Formulations, Perioperative Services)
Moses H. Cone Memorial Hospital
Greensboro, North Carolina

Patricia C. Kienle, BSPharm, MPA, BCSCP, FASHP*
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Solutions
Wilkes-Barre, Pennsylvania 

Kerrie Lee, PharmD, MA
Sterile Compounding Supervisor
Providence Infusion and Pharmacy Services
Tukwila, Washington 

Lisa McCabe, PharmD, MBA, BSN
Director, Health System Pharmacy
Cardinal Health
Tewksbury, Massachusetts 

Abby Roth, CMQ/QE
Owner/Microbiologist
Pure Microbiology LLC
Allentown, Pennsylvania 

Allison Young, PharmD, MS, BCSCP
Director of Pharmacy, Centralized Compounding
Integrated Service Center Pharmacy
Indiana University Health
Plainfield, Indiana

*Content matter experts

Angela T. Cassano, PharmD, BCPS, FASHP
Sue Dombrowski, MS, RPh

Anita Abata, PharmD, BCSCP, BCPS, BCCCP
Summer Abduqadir, PharmD, BCSCP
Leeja Abraham, BCSCP
Amir Aziz, PharmD, BCPS, BCPSP
Paul Baker, PharmD, BCSCP
Karen Bertch, PharmD, BCSCP, FCCP
Ashlyn Carter, PharmD, BCSCP
Leroy Carter, PharmD, BCSCP
Carmen Chang, PharmD, BCSCP
Flores Collin Roselle, BCSCP
Letitia Cooper, PharmD, CPh, BCSCP
Nicholas DePeel, PharmD, BCPS, BCSCP
Heather DeSanto, PharmD, BCSCP
Ghada Fakih, PharmD, BCSCP
Timothy Fine, PharmD, BCSCP
Michael Freudiger, PharmD, APh, BCPS, BCSCP
Erica Garris, PharmD
Zoe Glaras, PharmD, BCSCP
Joanne Glatz, PharmD, BCSCP
Ralph Grillo, PharmD, BCSCP
Alesia Hanson, RPh, BCSCP
Amanda Harding, PharmD, BCSCP
Kimberly Haverstick, PharmD, MBA, BCSCP
Eileen Hendrickson, PharmD, BSPharm, MBA, BCSCP
Emma Hews, PharmD, MBA, BCSCP
Angela Hobson, PharmD, BCSCP
Allison Hoff, RPh, BCSCP
Suet Huang, PharmD, BCSCP
Kim Hunt, RPh, BCSCP
Maisha Khan, PharmD, BCSCP
Susan Kleppin, RPh, BCSCP
Jessica Lee, PharmD, BCSCP
Daisy Leong, PharmD, BCPS, BCSCP
Richard Martin, PharmD, BCSCP
Ryan Martinez, PharmD, BCSCP
Koshy Mathew, PharmD, MBA, BCSCP
Vicki McConnell, BSPharm, PharmD
Helen McKnight, PharmD, MBA, DPLA, BCSCP
Kathleen McTernan, PharmD, BCSCP
Pam Meysenburg, PharmD, BCSCP
Wayne Moore, PharmD, BCSCP
Benjamin Myatt, PharmD, BCSCP
Ioana Necs, PharmD, BCSCP
Edmond Nunes, PharmD, BCSCP
Nima Osgo, BSCSP
Barbara Petroff, BS Pharm, BCSCP
Lauren Piccoli, Pharm.D. BCSCP
Deborah Pruski, BSPharm, BCSCP
Kelley Reece, PharmD, BCSCP
Jocelyn Reynoso, PharmD, BCPS, BCGP, BCSCP
Christine Riat, PharmD, BCSCP
Catherine Richwine, BS, BCSCP
Elizabeth Rogers, PharmD, MPH, CPPS, BCSCP
Gina Rosito, PharmD, BCSCP, APP
Christian Sawma, BSPharm, BCSCP
Elizabeth Schar, BS Pharm, DPLA, BCSCP
Andrew Schwierjohn, PharmD, BCSCP
Marwa Sherif, BSc, BCSCP, CPHQ
Ileana C Soto, PharmD, BCSCP
Kathy Stone, PharmD, BCSCP
Heather Taxeras, PharmD, BCSCP
Kelly Taylor, PharmD, BCSCP
Ann Usherenko, Pharm D BCSCP
Morgan Walker, PharmD, MBA, BCSCP, CPH
LaKeashia Watson, PharmD, BCSCP

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following persons in control of this activity’s content have relevant financial relationships:

• Kevin N. Hansen is a member of the USP Compounding Expert Committee, however this presentation is not affiliated or endorsed by USP.
• Patricia Kienle is a member of the USP Compounding Expert Committee, however this presentation is not affiliated or endorsed by USP. 

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

These activities were developed by ASHP.